New Cousteau-Linked...
Health Care: Health Services
Bio-Reference Labs Inc. (BRLI: NASDAQ)
$19.26 0.88 | 4.79%
06/04/12 - 04:00 PM ET
Company Cash Flow
| Oct 2011 | Oct 2010 | Oct 2009 | Oct 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 36.36M | 26.38M | 21.85M | 15.62M |
| Operating Gains/Losses | 1.68M | 368.00K | 271.00K | 321.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -29.25M | -32.98M | -21.68M | -11.70M |
| (Increase) Decrease in Inventories | -3.50M | -2.04M | -417.00K | -611.00K |
| (Increase) Decrease In Other Current Assets | -1.64M | -941.00K | -108.00K | -328.00K |
| (Decrease) Increase In Payables | 6.54M | 6.57M | 9.58M | 5.33M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | 11.62M | 7.95M | 10.15M | 3.82M |
| Other Non-Cash Items | 40.00K | 290.00K | 40.00K | 92.00K |
| Net Cash From Continuing Operations | 30.95M | 13.40M | 24.37M | 18.88M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 30.95M | 13.40M | 24.37M | 18.88M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -14.12M | -16.49M | -8.89M | -7.98M |
| Acquisitions | -1.42M | -1.92M | -1.92M | -1.92M |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -15.54M | -18.41M | -10.81M | -9.90M |
| Issuance of Debt | -7.52M | 8.96M | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 498.00K | 797.00K | 843.00K | 542.00K |
| Repayment of Long-Term Debt | -4.15M | -3.97M | -10.10M | -8.27M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | -452.00K |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | -11.17M | 5.79M | -9.26M | -8.18M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 4.23M | 784.00K | 4.30M | 799.00K |
Portfolios with BRLI
- Portfolio NameUser Type
- Contributor10 Small-Cap Stocks Poised ...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ContributorSmall-Caps With Big Potential
- UserSPECULATIVE
- ContributorEarnings Short Squeeze Play...
- ContributorThree Growth Stocks for a B...
- UserRFW2
- ContributorTop 5 Small-Cap Stocks: Aug...
Latest BRLI Headlines from TheStreet
- Jarden, Bio-Reference Labs: Time to Buy? 03.15.12 | 03:03 pm
- Time To Jump Into Jarden, Bio-Reference Labs
03.15.12 | 05:03 am - 10 Small-Cap Stocks Poised to Rise, History Shows (Update1) 03.13.12 | 10:03 am
- Bio-Reference Labs Inc. Stock Upgraded (BRLI) 02.01.12 | 06:02 am
- Bio-Reference Labs Inc. Stock Downgraded (BRLI) 11.28.11 | 05:11 am
- Bio-Reference Rises On Unusually High Volume (BRLI) 11.08.11 | 01:11 pm
- Bio-References Not Done Growing, Says CEO 09.09.11 | 05:09 am
- 5 Earnings Short-Squeeze Plays 08.23.11 | 01:08 pm
- Bio-Reference Reaches New 52-Week High (BRLI) 05.26.11 | 10:05 am
- Heavily Shorted Stocks That Could Pop on Earnings 05.24.11 | 07:05 am
Press Releases for BRLI
- BioReference Laboratories, Inc. Announces Earnings Date For Second Quarter Fiscal Year 2012 - Business Wire 05.31.12 | 08:05 am
- Bio-Reference Laboratories, Inc. Announces Record First Quarter Revenue, Earnings And Cash Flow From Operations - Business Wire 03.01.12 | 08:03 am
- Bio-Reference Laboratories, Inc. Announces Earnings Date For First Quarter Fiscal Year 2012 - Business Wire 02.23.12 | 08:02 am
- BioReference Announces 2012 Annual Meeting Date - Business Wire 02.08.12 | 03:02 pm
- BioReference To Launch Groundbreaking Solid Tumor Genotyping Test Through Its GenPath Oncology Laboratory - Business Wire 01.26.12 | 08:01 am
- BioReference Laboratories, Inc. Announces Contract With Corizon, Inc. To Provide Correctional Healthcare Laboratory Services - Business Wire 01.12.12 | 08:01 am
- Bio-Reference Laboratories, Inc. Announces Record Revenues, Earnings And Cash Flow For Fourth Quarter And Full Fiscal Year - Business Wire 12.08.11 | 08:12 am
- BioReference Laboratories, Inc. Announces Earnings Date For Fourth Quarter And Year End For Fiscal Year 2011 - Business Wire 12.07.11 | 02:12 pm
- BioReference Laboratories, Inc. To Speak At The Oppenheimer 22nd Annual Healthcare Conference - Business Wire 12.07.11 | 08:12 am
- Bio-Reference Laboratories, Inc. And McKesson Specialty Health’s Onmark GPO Execute Purchasing Agreement - Business Wire 11.22.11 | 02:11 pm
Partner Headlines for BRLI
- Bio Reference Labs, Quest Diagnostics Inc., Laboratory Corp. Of America: Diagnosis Profits - Seeking Alpha 03.05.12 | 08:03 am
- 10 Highly Shorted, Rallying Stocks With Strong Sources Of Profitability - Seeking Alpha 02.02.12 | 08:02 am
- Bio-Reference: Loads Of Dirty Laundry - Seeking Alpha 11.13.11 | 09:11 am
- Jefferies Places Bio-References Labs Under Review - Benzinga 11.11.11 | 09:11 am
- UPDATE: StreetSweeper Posts Negative Article on Bio-Reference - Benzinga 11.10.11 | 01:11 pm
- Questions Raised Over Bio-Reference Labs - Benzinga 11.01.11 | 01:11 pm
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 09.29.11 | 09:09 am
- Upgrades, Downgrades, Initiations and Other Changes for Friday - Seeking Alpha 05.27.11 | 04:05 pm
- 10 Health Care Companies You Can Be Proud to Own - Benzinga 04.08.11 | 06:04 pm
- Benzinga’s Volume Movers (MNTA, HAIN, BRLI, PAAS) - Benzinga 08.26.10 | 01:08 pm
